WEREWOLF THERAPEUTICS, INC. Debt Instrument, Interest Rate, Effective Percentage
WEREWOLF THERAPEUTICS, INC. (HOWL) had Debt Instrument, Interest Rate, Effective Percentage of 19.24% as of 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Notes › Debt Instruments
us-gaap:DebtInstrumentInterestRateEffectivePercentage · last filed 2026-09-22
- 2026-06-30: Debt Instrument, Interest Rate, Effective Percentage 19.24%.
- 2026-03-31: Debt Instrument, Interest Rate, Effective Percentage 19.24%.
- 2025-12-31: Debt Instrument, Interest Rate, Effective Percentage 19.24%.
- 2025-09-30: Debt Instrument, Interest Rate, Effective Percentage 19.24%.
| Period end | Debt Instrument, Interest Rate, Effective Percentage |
|---|---|
| 2026-06-30 | 19.24% 10-Q · filed 2026-07-31 |
| 2026-03-31 | 19.24% 10-Q · filed 2026-05-07 |
| 2025-12-31 | 19.24% S-4 · filed 2026-09-22 |
| 2025-09-30 | 19.24% 10-Q · filed 2025-11-04 |
| 2025-06-30 | 19.24% S-4 · filed 2026-09-22 |
| 2025-03-31 | 19.24% 10-Q · filed 2025-05-08 |
| 2024-12-31 | 19.24% 10-K · filed 2025-03-11 |
| 2024-09-30 | 19.24% 10-Q · filed 2024-11-07 |
| 2024-06-30 | 19.24% 10-Q · filed 2024-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |